{"id":"W2405208786","doi":"10.1016/j.jval.2016.03.233","title":"Manager, Health Economics and Patient Access","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Notre-Dame; University of Calgary; Novartis (Canada)","funders":"","keywords":"Fingolimod; Natalizumab; Teriflunomide; Discontinuation; Medicine; Glatiramer acetate; Internal medicine; Medical prescription; Multiple sclerosis; Brace; Physical therapy; Pharmacology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004267323,0.0001230185,0.0002692419,0.0001357521,0.0001875617,0.00001319541,0.0001779553,0.00007995962,0.00006118685],"category_scores_gemma":[0.0000303315,0.00009207741,0.00003173446,0.00009163137,0.0001262699,0.0001400911,0.0001079262,0.0001252914,0.00008629655],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001252365,"about_ca_system_score_gemma":0.0002256855,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004608757,"about_ca_topic_score_gemma":0.00002924947,"domain_scores_codex":[0.9984873,0.0002716628,0.0004620266,0.0002782522,0.00001465622,0.0004861376],"domain_scores_gemma":[0.9994405,0.0001158331,0.0001875534,0.0002330914,0.000009498383,0.00001355695],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000755506,0.0001895125,0.002296938,0.0001084933,0.00002411275,0.000001205065,0.001978656,0.0002460956,0.0004132786,0.01603782,0.0007148815,0.9779134],"study_design_scores_gemma":[0.004685233,0.001059909,0.07199978,0.0006637826,0.000004210715,0.00006417304,0.001491437,0.0001052192,0.001250257,0.006247479,0.9118515,0.0005770646],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8793882,0.1021443,0.00009543577,0.0164673,0.0008779247,0.0004105358,0.00002753781,0.00004836253,0.0005403933],"genre_scores_gemma":[0.9807142,0.01677088,0.00002074735,0.002202027,0.000001787247,0.0000148425,0.000008708244,0.00001198494,0.0002548395],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9773364,"threshold_uncertainty_score":0.6967093,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02306125399034103,"score_gpt":0.2639696351950183,"score_spread":0.2409083812046772,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}